Platform Why Features Security Score AI Engine AI Coding KYP Hub Pricing Company About Buckler News Contact Français Book Demo →
Part One

Canada

Canada's securities regulators have published the most detailed guidance of the two countries, and it speaks directly to registered dealers and advisers.

1
CSA Staff Notice 11-348
The principal Canadian guidance on AI systems in capital markets

In December 2024 the CSA published Staff Notice and Consultation 11-348, Applicability of Canadian Securities Laws and the use of Artificial Intelligence Systems in Capital Markets.[1] It is staff guidance on how existing law applies, not a new rule. Its starting point:

"Securities laws are generally technology-neutral and apply regardless of the technology being used to carry out a given activity."[1]

It adds an important qualification: "Depending on the technology, different actions may be necessary to meet the same requirements under securities law."[1] In other words, the obligation stays the same, but the controls needed to meet it change with the tool.

What the Notice Expects
ThemeWhat CSA Staff Said
Governance"Governance and risk management practices should be paramount" for regulated market participants deploying AI systems.
Fit for purposePolicies should cover planning, design, verification and validation, "including being satisfied that the AI system is fit for purpose and that robust testing prior to deployment has taken place."
Human in the loopPolicies can include "having a 'human-in-the-loop', where humans can effectively monitor the input and/or output of an AI system."
Ongoing testingStaff "emphasize the importance of regularly testing the AI system and the results of its use before and after its adoption."
ExplainabilityFirms should balance advanced capabilities against explainability; staff favour "the highest degree of explainability that is feasible" for the type of system.
Record keepingAI systems "should provide an appropriate degree of explainability so that registered firms are able to meet applicable record keeping requirements."
AI washingInaccurate, misleading or embellished claims about AI use "may be misleading to the public or constitute a misrepresentation."
Three Levels of Use

For dealers and advisers, the notice distinguishes between how much decision-making is handed to the system:

Decision Support
Using AI for research and analysis is "not inherently problematic" if the firm verifies the quality of the information and treats the output as "no more than an input" to its own decisions.
Limited Automation
AI can make decisions that execute automatically, with human oversight but without direct human intervention, "provided such decisions are within narrowly prescribed constraints."
Replacing the Registrant
Staff do not believe an AI system can currently act as a substitute for an advising representative as the decision-maker for clients' investments and consistently meet regulatory requirements.
Disclosure
Staff see disclosure of AI use as giving investors greater transparency, and warn against vague, jargon-heavy claims made to attract investors.

For product research and due diligence, the decision-support category is the one that matters most. An AI system can read, extract and summarize, but the firm must verify what it produces and make its own assessment.

2
Automated Systems in KYP
What the December 2025 KYP review said about algorithms and automation

A year after 11-348, the CSA and CIRO published Staff Notice 31-368, the results of their review of 105 firms' KYP and related practices.[2] It doesn't address AI as a separate topic, but it speaks to automated systems in two places that apply directly to AI tools used in product review:

  • Oversight of algorithmic models. Where firms rely on algorithmic models, staff noted the need for evidence of ongoing oversight. Setting up the model is not enough; the firm has to show it continues to watch it.[2]
  • Policies that describe automation. Staff expect firms' policies and procedures to describe automated systems in detail, so that the firm's process can be understood and tested.[2]

The same review found that "annual monitoring alone was not found to be sufficient" for products on the shelf.[2] This is one reason firms are turning to automated monitoring. It also means the automation itself becomes part of what the firm has to supervise and evidence.

3
CIRO and OSFI
The self-regulator's exam focus, and model risk rules for bank-owned firms

CIRO. CIRO's 2026 Compliance Report identifies AI as a focus area for dealers. It expects firms to understand and document where they use AI across the business, to have policies and controls for the risks it creates, and to consider whether a new use of AI or automation is a material business change that requires advance notice to CIRO. CIRO's compliance teams will review operational controls to confirm AI tools are working as designed.[3]

OSFI. Many Canadian dealers and advisers sit inside a bank or insurer. For those groups, OSFI's Guideline E-23 on model risk management, published in September 2025 and effective May 1, 2027, applies to federally regulated financial institutions.[4] It defines a model to include AI and machine learning methods, covers models and data sourced from third-party vendors, and requires a comprehensive, current inventory of models whose risk is not negligible.[4] An AI tool used to screen or monitor products inside a bank-owned firm is likely to fall within the group's model risk framework.

Part Two

United States

US regulators have taken the same technology-neutral line, delivered mostly through FINRA guidance, SEC exam priorities and enforcement.

1
FINRA
Regulatory Notice 24-09 and the 2026 Oversight Report

In June 2024, FINRA issued Regulatory Notice 24-09, reminding member firms of their obligations when using generative AI.[5]

"FINRA's rules - which are intended to be technology neutral - and the securities laws more generally, continue to apply when member firms use Gen AI or similar technologies."[5]

Two points in the notice matter for product due diligence:

  • Vendor tools are covered. FINRA rules apply whether firms build AI tools themselves "or when leveraging the technology of a third party, including through embedded features in existing third-party products."[5]
  • Evaluate before deploying. Firms should evaluate AI tools before deploying them and make sure they can continue to comply with existing rules. Where AI is used in supervisory systems, policies should address "technology governance, including model risk management, data privacy and integrity, reliability and accuracy of the AI model."[5]

FINRA's 2026 Annual Regulatory Oversight Report, published in December 2025, returns to the topic.[6] It observes that the most common use of generative AI among member firms is summarization and information extraction, which is exactly the work AI does in reading offering documents and filings. Among the practices it describes are formal review and approval of AI use cases, a supervision, governance or model risk management framework, "robust testing" of capabilities and limitations, and "ongoing monitoring of prompts, responses and outputs," including "validation and human-in-the-loop review."[6]

The report also flags a newer risk: AI agents that act autonomously, without a person validating each step. FINRA points to the risk of agents acting beyond their intended scope, and to the difficulty of auditing what they did.[6]

2
The SEC
Exam priorities, enforcement, and a withdrawn rule
DateActionWhat It Means
March 2024Settled charges against two investment advisers, Delphia and Global Predictions, for false and misleading statements about their use of AI; combined penalties of $400,000[8]Claims about AI capabilities are held to the same standard as any other representation
June 2025Withdrawal of the 2023 proposal on conflicts of interest from predictive data analytics, along with other pending proposals[9]No AI-specific rule is pending; existing obligations govern
FY2026Examination priorities list AI under emerging financial technology[7]AI use is reviewed in exams now

The SEC's Division of Examinations says it will review registrants' representations about their AI capabilities for accuracy, and assess whether firms "have implemented adequate policies and procedures to monitor and/or supervise their use of AI technologies."[7] The withdrawal of the 2023 proposal removed a possible AI-specific rule, but it didn't remove the scrutiny. The practical result is the same as in Canada: existing obligations, applied to new tools, tested in exams.

Part Three

What It Means for KYP

Read together, the guidance from both countries is consistent. For firms using AI to research and monitor products, it comes down to a short list of expectations.

1
The Common Threads
Where Canadian and US regulators agree
ThemeCanadaUnited States
Existing rules applySecurities laws are technology-neutral (CSA 11-348)FINRA rules are technology neutral and continue to apply (RN 24-09)
GovernanceGovernance and risk management "paramount"; document AI use (CSA, CIRO); model risk management for bank groups (OSFI E-23)Formal review and approval of use cases; governance or model risk framework (FINRA)
TestingFit for purpose; tested before and after adoption (CSA)Evaluate before deploying; robust testing (FINRA)
Human oversightHuman in the loop; output treated as an input, not a decision (CSA)Human-in-the-loop review; caution on autonomous agents (FINRA)
Ongoing oversightEvidence of ongoing oversight of algorithmic models (31-368)Ongoing monitoring of outputs (FINRA); supervision of AI use reviewed in exams (SEC)
Explainability and recordsExplainability sufficient to meet record keeping requirements (CSA)Auditability a stated risk for AI agents (FINRA)
Third-party toolsVendor models within scope of model risk management (OSFI E-23)Rules apply to third-party and embedded tools (FINRA)
Accurate claimsAI washing may be a misrepresentation (CSA)Enforcement for misleading AI claims; representations reviewed in exams (SEC)

The one line no regulator in either country has crossed is accountability. None has suggested that using an AI tool changes who is responsible for understanding a product. The firm approves the product; the advisor understands what they recommend; the AI helps both do that faster.

2
AI Across the KYP Process
Common uses, and the control each one needs
UseWhat the AI DoesMain RiskControl
Document extractionPulls fees, terms, parties and risk factors from prospectuses, offering memoranda and term sheetsWrong or missing values presented confidentlyEvery extracted value linked to its source page; sample checked by a person
SummarizationDrafts product summaries and change noticesPlausible text that omits or misstates a riskHuman review and sign-off before issue; summary cites its sources
Change detectionCompares new filings and data against the product's file and flags differencesMissed changes; silent failures when data is unavailableTested against known changes; failures reported, not skipped
Scoring and screeningRanks or scores products against criteriaOpaque results the firm can't explainDocumented methodology; outputs explainable to a reviewer and an examiner
Research assistanceAnswers questions about a product for analysts or advisorsUnsupported or invented answersAnswers grounded in and linked to source documents; treated as an input only
Autonomous agentsTakes multi-step actions, such as updating records or statusesActs beyond scope; hard to auditNarrow permissions; no status or approval changes without a person; full action log

Sources are the control that runs through all of these. When every AI output can be traced to the document, page or data point it came from, a reviewer can check it, an advisor can rely on it, and an examiner can follow it. When it can't, the firm is left defending text it can't verify.

3
Responsibilities and Written Process
What the firm and the advisor each need to do
What the Firm Needs to Do
  • Inventory AI use. Every AI tool in the KYP process, including features embedded in vendor products.
  • Approve before use. Assess each use case for fitness for purpose and test it before deployment.
  • Describe it in policy. What each tool does, its inputs, its limits and who oversees it, in enough detail to test.
  • Keep a person accountable. AI output is an input to the firm's assessment, never the approval itself.
  • Require sources. Outputs used in product files must link to the documents or data they came from.
  • Monitor and retest. Check outputs on a schedule and after any model or vendor change; keep the evidence.
  • Consider notification. In Canada, assess whether a new AI use is a material business change requiring notice to CIRO.
  • Describe AI accurately. Make no claim about AI use, internally or externally, that the firm can't support.
What the Individual Advisor Needs to Do
  • Use approved tools only. Not public AI tools for product research on client matters unless the firm has approved them.
  • Treat output as a starting point. Check AI summaries against the source before relying on them.
  • Keep their own understanding. An AI summary doesn't replace the advisor's own knowledge of a product's structure, features, risks and costs.
  • Report errors. Flag AI output that is wrong or unsupported so the firm can fix and retest.
  • Describe AI accurately. Don't overstate to clients what the firm's AI tools do.
Example: Written Process for AI in Product Due Diligence and Monitoring
Illustrative
1
Inventory. The firm maintains an inventory of every AI system used in product due diligence and monitoring, including AI features embedded in third-party products, recording its purpose, inputs, outputs, owner and approval date.
2
Approval. No AI system is used in the KYP process until the Product Committee, with Compliance and Technology, has approved the use case, confirmed the system is fit for purpose and reviewed the results of pre-deployment testing.
3
Description. This policy's appendix describes each approved system in detail: what it does, the data it uses, its known limitations, and the human review applied to its outputs.
4
Human accountability. AI outputs are inputs to the firm's assessment. Product approvals, status changes and review decisions are made and recorded by named individuals. AI systems are not permitted to change a product's status.
5
Sources. AI outputs included in a product file or issued to advisors must identify the documents or data they are drawn from. Outputs without a source are not used.
6
Monitoring and retesting. Each system's outputs are sample-checked against source documents monthly and retested after any change to the model, vendor or data source. Results and remediation are recorded.
7
Change and notification. Compliance assesses each new AI use, and each material change to an existing one, for any regulatory notification required.
8
Representations. Statements about the firm's use of AI, in marketing, client communications or regulatory filings, are reviewed by Compliance for accuracy before use.
Five Questions to Test AI in a KYP Program
  1. Does the firm know every place AI touches its product due diligence, including inside vendor tools?
  2. Could the firm explain to an examiner how each tool produced a given output?
  3. Can every AI-generated product summary be traced back to its source documents?
  4. Is there evidence that outputs are checked on an ongoing basis, not just at launch?
  5. Does every statement the firm makes about its use of AI match what the tools actually do?
A note on scope: This article summarizes publicly available regulatory publications as of its date, focused on the use of AI in product due diligence and monitoring. It does not cover every AI-related obligation, such as privacy law or the use of AI in client-facing advice. It is general information, not legal or compliance advice. The responsibilities, use-case controls and written process are illustrations, not prescribed requirements.
References
  1. Canadian Securities Administrators. CSA Staff Notice and Consultation 11-348, Applicability of Canadian Securities Laws and the use of Artificial Intelligence Systems in Capital Markets, December 5, 2024. Source document (PDF)
  2. Joint CSA/CIRO Staff Notice 31-368, Client Focused Reforms: Review of Registrants' Know Your Client, Know Your Product and Suitability Determination Practices and Additional Guidance, December 10, 2025. Oversight of algorithmic models, pp.15-16; monitoring, p.18; policies describing automated systems, p.34. Source document (PDF)
  3. Canadian Investment Regulatory Organization. Compliance Report 2026. Source document
  4. Office of the Superintendent of Financial Institutions. Guideline E-23 - Model Risk Management (2027), published September 11, 2025, effective May 1, 2027. Source document
  5. FINRA. Regulatory Notice 24-09, FINRA Reminds Members of Regulatory Obligations When Using Generative Artificial Intelligence and Large Language Models, June 27, 2024. Source document
  6. FINRA. 2026 Annual Regulatory Oversight Report, December 2025. Generative AI, pp.24-28. Source document (PDF)
  7. U.S. Securities and Exchange Commission, Division of Examinations. Fiscal Year 2026 Examination Priorities. Source document (PDF)
  8. U.S. Securities and Exchange Commission. Press Release 2024-36, SEC Charges Two Investment Advisers with Making False and Misleading Statements About Their Use of Artificial Intelligence, March 18, 2024. Source document
  9. U.S. Securities and Exchange Commission. Withdrawal of Proposed Regulatory Actions, Release No. 33-11377, June 2025 (effective June 17, 2025). Source document (PDF)